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OXA-48-like beta-lactamase producing bacteria are 
now endemic in several European and Mediterranean 
countries. Among this carbapenemase family, the OXA-
48 and OXA-181 variants predominate, whereas other 
variants such as OXA-204 are rarely reported. Here, 
we report the molecular epidemiology of a collection 
of OXA-204-positive enterobacterial isolates (n = 29) 
recovered in France between October 2012 and May 
2014. This study describes the first outbreak of OXA-
204-producing Enterobacteriaceae in Europe, involving 
12 isolates of an ST90  Escherichia coliclone and nine 
isolates of an ST147  Klebsiella pneumoniae  clone. All 
isolates co-produced the cephalosporinase CMY-4, 
and 60% of them co-produced the extended-spectrum 
beta-lactamase CTX-M-15. The  blaOXA-204  gene was 
located on a 150-kb IncA/C plasmid, isolated from 
various enterobacterial species in the same patient, 
indicating a high conjugative ability of this genetic 
vehicle.
Introduction
Since the 2000s, the carbapenem-hydrolysing beta-
lactamase OXA-48 has rapidly and widely dissemi-
nated and is now endemic in several European and 
Mediterranean countries [1-4]. Since its discovery, 
eleven variants of OXA-48 have been reported, clas-
sified into two main groups [1,5-13]. The first group 
contains variants with significant carbapenemase 
activity, such as OXA-48, OXA-162, OXA-181 or OXA-204 
[5-7]. Some variants, such as OXA-232 and OXA-244, 
possess a hydrolytic profile similar to that of OXA-48 
but have a lower capacity to hydrolyse imipenem and 
temocillin [8-10]. The second group of OXA-48-like vari-
ants includes beta-lactamases with extended-spec-
trum hydrolysis properties and without any significant 
carbapenemase activity because of deletions in the 
active site of the enzyme, such as OXA-163, OXA-247, 
or OXA-405 [11-13]. In most of these cases, the blaOXA-48-
like genes are plasmid-borne and are associated with 
insertion sequences involved in their mobilisation and 
expression [1,7,9].
OXA-204 was first identified in 2012 in a  Klebsiella 
pneumoniae  isolate from Tunisia [7]. In this strain, 
the  blaOXA-204was co-located with a  blaCMY-4  gene on a 
conjugative IncA/C-type plasmid [7]. The blaOXA-204 gene 
was part of a transposon Tn2016 that consisted of one 
copy of insertion sequence (IS) ISEcp1, disrupted by an 
ISKpn15  element, and a truncated  lysR  transcriptional 
regulator [7]. Since that report, OXA-204 has only been 
identified in two other  K. pneumoniae  isolates and a 
single  Escherichia coli  isolate, all recovered in Tunisia 
[14,15]. In those two strains, the  blaOXA-204  gene was 
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associated with the ISEcp1 element, in one of the two 
cases truncated by another IS element [14,15].
Our study aimed to compare the genetic features of 
OXA-204 beta-lactamase-producing strains recovered 
in France by analysing a collection of 29 blaOXA-204-pos-
itive enterobacterial isolates recovered from October 
2012 to May 2014. The genetic context and the location 
of the blaOXA-204 gene were investigated. Finally, a clonal 
relationship analysis allowed us to identify a regional 
outbreak in France possibly related to an endoscope.
Methods
Bacterial isolates
We investigated a total of 29 OXA-204 beta-lacta-
mase-producing enterobacterial isolates. All isolates 
had been recovered from clinical specimens and had 
been received between October 2012 and May 2014 
at the National Reference Centre (NRC) for Antibiotic 
Resistance (division of carbapenemase-produc-
ing  Enterobacteriaceae), France. The distribution of 
clinical samples was as follows: 12 rectal swabs, 12 
urine samples, four bile samples and one pus speci-
men. Isolates were identified using matrix-assisted 
laser desorption ionization time-of-flight (MALDI-TOF) 
mass-spectrometry (Maldi Biotyper, Bruker Daltonics, 
France).
Susceptibility testing
Antimicrobial susceptibilities were determined by disk 
diffusion method on Mueller-Hinton agar (Bio-Rad, 
Marnes-la-Coquette, France) and interpreted accord-
ing to the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) guidelines [16]. In addi-
tion, minimal inhibitory concentrations (MICs) were 
determined for carbapenems (imipenem, meropenem, 
ertapenem) and tigecycline using E-tests (bioMérieux, 
Marcy-l’Etoile, France), and for colistin using broth 
microdilution according to EUCAST recommendations.
PCR and sequencing of beta-lactamase-
encoding genes
Whole-cell DNA was extracted using the QiaAmp 
DNA minikit (Qiagen, Courtaboeuf, France). All 
isolates were screened by PCR for the Ambler 
class A, B and D carbapenemase-encoding 
genes  blaKPC,  blaIMP,  blaVIM,  blaNDM  and  blaOXA-48-like  as 
previously described [6,17,18]. Detection of other 
beta-lactamase genes such as  blaCTX-M  and  blaAmpC-
like  was performed with internal primers, as described 
previously [17]. PCR products were analysed on aga-
rose gel. In case of positive signal, the full-length 
genes (basically  blaCTX-M  and  blaCMY) were amplified 
and sequenced by using the amplification prim-
ers with an automated sequencer (ABI PRISM 3100; 
Applied Biosystems) as previously described [17]. 
The nucleotide and deduced protein sequences were 
analysed with software from the National Center for 
Biotechnology Information (www.ncbi.nlm.nih.gov).
Strain typing
Multilocus sequence typing (MLST) with seven house-
keeping genes (rpoB, gapA, mdh, pgi, phoE, infB and t
onB) was performed for K. pneumoniae isolates according 
to Diancourt et al. [19]. Allele sequences and sequence 
types (STs) were verified at the Institut Pasteur’s 
whole genome MLST database [20]. Fragments of 
seven housekeeping genes (adk,  fumC, gyrB,  icd, mdh
,  purA  and  recA) were amplified and sequenced for  E. 
coli  isolates as described on EnteroBase [21]. A differ-
ent allele number was given to each distinct sequence 
within a locus, and a distinct ST number was attributed 
to each distinct combination of alleles.
Figure 1
Rep-PCR analysis of OXA-204-producing 
Enterobacteriaceae, France, 2012–14 (n = 21)
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Dendrogram and computer-generated image of rep-PCR banding 
patterns of OXA-204-producing Klebsiella pneumoniae (A) and 
OXA-204-producing E. coli (B) isolates. Epidemic clones (ST90 
Escherichia coli and ST147 K. pneumoniae are highlighted in 
bold. The red similarity line at 95% shows the cut-off to separate 
different clone.
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Clonality analysis using repetitive element 
palindromic PCR (rep-PCR)
To evaluate their clonal relationship, all  E. coli  and  K. 
pneumoniae  isolates were subjected to Diversilab, a 
semi-automated rep-PCR (bioMérieux, Marcy-L’Etoile, 
France). As recommended by the manufacturer, a cut-
off for similarity of 95% defined a cluster.
Plasmid DNA analysis and mating-out assays
Plasmid DNAs were extracted using the Kieser method 
[22], and analysed by agarose gel electrophoresis 
using the  E. coli  NCTC50192 strain that harbours four 
plasmids of 154, 66, 48 and 7 kb as plasmid size 
marker. Direct transfer of the carbapenem resistance 
markers was attempted by liquid mating-out assays 
at 37 °C using sodium azide-resistant  E. coli  J53 as 
recipient, as previously described [23]. Selection was 
performed on agar plates supplemented with ertape-
nem (0.5 µg/mL) and sodium azide (100 µg/mL).
Replicon and transposon typing
PCR-based replicon typing of the main plasmid incom-
patibility groups reported in  Enterobacteriaceae  was 
performed as previously described [24]. Genetic struc-
tures surrounding the  blaOXA-204  gene were determined 
using the primers listed in Table 1. 
Results 
Bacterial isolates
A total of 29 OXA-204-producing enterobacterial iso-
lates were received at the NRC for Antibiotic Resistance 
from October 2012 to May 2014. These isolates were 
sent to the NRC because they exhibited decreased 
susceptibility to carbapenems and/or because they 
were isolated from a patient who was identified in 
epidemiological investigations around an infected or 
colonised patient. These isolates included 11 K. pneu-
moniae, 15 E. coli, one Proteus mirabilis,one Citrobacter 
freundii and one Serratia marcescens (Table 2). The 29 
strains were isolated from 24 patients. Of these 29 
Figure 2
Synoptic curve of patients involved in the endoscope-related outbreak caused by OXA-204-producing Enterobacteriaceae, 
France, 2012–14 (n = 22)
1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12
X
X
X
X
X
X
X
X
X
X
Hospital 1
Endoscopy center
Hospital 2
Hospital 3
X
Private clinic 1
Retirement home 1
Hospital 4
Hospital 5
Retirement home 2
Hospital 6
2012 2013 2014
E. coli ST90
E. coli ST949
E. coli ST617
E. coli ST104
K. pneumoniae ST147
K. pneumoniae ST1683
K. pneumoniae ST1709
S. marcescens 
X Endoscopy
Patient-to-patient transmission
Strains:
X
X
X
X
X
X
X
X
X
X
X
X
X X
1
3
4
2
5
7
8
6
9
(11)
12
(10)
(13)
15
(16)
(14)
17
19
20
18
21
22
Patients
Patient numbers are indicated on the left of each time line. Numbers in parenthesis indicate patients who were not in direct contact with the 
suspectedly contaminated endoscope. Crosses indicate the date of endoscopy with the suspectedly contaminated endoscope and coloured 
boxes correspond to hospitalisations. Black arrows represent direct patient-to-patient transmission of the OXA-204-producing K. pneumoniae 
ST147.
4 www.eurosurveillance.org
OXA-204 producers, 27 were isolated from 22 patients 
(n = 22) located in the same geographical area (Paris 
area, Ile-de-France).
Susceptibility to beta-lactams and related beta-
lactamase genes
According to the EUCAST guidelines, 21 isolates were 
susceptible to imipenem and meropenem. Of the 
15  E. coliisolates, 14 were susceptible to imipenem 
and meropenem whereas only four of the 11  K. pneu-
moniae  isolates were susceptible to those antibiotics 
(Table 2). By contrast, 21 of the 29 OXA-204 produc-
ers had a decreased susceptibility (intermediate or 
resistant) to ertapenem (7/15 of the  E. coli  and 11/11 
of the  K. pneumoniae isolates). All  P. mirabilis,  C. fre-
undii  and  S. marcescens  isolates were susceptible to 
imipenem and meropenem and had decreased suscep-
tibility to ertapenem (Table 2). Regarding the broad-
spectrum cephalosporins, all isolates were resistant 
to ceftazidime and cefotaxime. Since OXA-204 has no 
hydrolytic activity towards broad-spectrum cephalo-
sporins, we searched for the expression of additional 
beta-lactamases (extended-spectrum beta-lactamases 
(ESBLs) and/or cephalosporinases). As expected, all 
OXA-204-producing isolates co-produced an AmpC-
type beta-lactamase, CMY-4 (Table 2). In addition, 18 
isolates were of intermediate susceptibility or resist-
ant to cefepime (nine E. coli isolates and nine K. pneu-
moniae  isolates). CMY-4 and OXA-204 are not able to 
hydrolyse cefepime, but co-production of the CTX-M-15 
ESBL was found in all those isolates (Table 2).
Susceptibility to non-beta-lactams antibiotics
Four antibiotics were active against the majority of 
the isolates. Except for the P. mirabilis and S. marces-
cens isolates that are intrinsically resistant to polymyx-
ins, all other OXA-204 producers were susceptible to 
colistin. In addition, 28, 26 and 22 of the 29 OXA-204 
producers were susceptible to amikacin, tigecycline 
and fosfomycin, respectively (Table 2). Conversely, 22 
OXA-204 producers were resistant to sulfamethoxa-
zole-trimethoprim, and 24 were resistant to ciprofloxa-
cin and gentamicin (Table 2).
Multilocus sequence typing
ST90 was the most commonly observed ST for the  E. 
coli isolates, accounting for 12 of 15 isolates. The three 
remaining single isolates belonged to ST104, ST617 
and ST949 (Table 2). Among the 11 OXA-204-positive K. 
pneumoniae  isolates, nine isolates belonged to ST147. 
The remaining two isolates belonged to the new ST1683 
and ST1709 (Table 2).
Genetic support of the blaOXA-204 gene
Using mating-out assays, transconjugants harbouring 
the  blaOXA-204  and the  blaCMY-4  genes were obtained for 
all 29 strains. Plasmid DNA analysis of those transcon-
jugants revealed a single plasmid (ca 150 kb), which 
was identified as an IncA/C-type plasmid (Table 2).
Close genetic environment of the blaOXA-204 
gene
The genetic environment of the  blaOXA-204  gene was 
analysed using specific primers designed from the 
plasmid p204-B of  K. pneumoniae 204 (Table 1). For 
17 strains, the  blaOXA-204  gene was part of transposon 
Tn2016,  where ISEcp1was disrupted by insertion of 
ISKpn15. This transposon was identified in the 12 
ST90  E. coli  strains and in five other single isolates 
(Table 2). In the 12 remaining isolates (nine ST147  K. 
pneumoniae  isolates and three single isolates), 
ISEcp1 was not disrupted by ISKpn15 element (Table 2).
Endoscopy-related outbreak
Rep-PCR analysis confirmed the MLST results and 
showed that 12 of the 15 OXA-204-producing  E. 
coli  isolates (all ST90  E. coli) and nine of the 12 OXA-
204-producing  K. pneumoniae  isolates (all ST147  K. 
pneumoniae) were clonally related (Figure 1).
The results of this analysis led us to do an epidemio-
logically investigation of this dual outbreak (ST90  E. 
coli  and ST147  K. pneumoniae). An endoscope was 
identified as the possible source of the outbreak in that 
the investigation showed that 17 patients had direct 
contact with the endoscope, while five (Patients 10, 
11, 13, 14 and 16) were considered as secondary cases 
through patient-to-patient transmission on a clinical 
ward (Figure 2). 
Of note, retrospective screening of all patients who 
had endoscopy with the suspectedly contaminated 
endoscope but were not hospitalised identified two 
colonised patients who underwent endoscopy as out-
patients (Patients 6 and 17) (Figure 2). In addition, 
for four patients, transmission of a  blaOXA-204-carrying 
plasmid from one strain to another was observed (sev-
eral enterobacterial isolates of different species car-
rying the same plasmid with the same close genetic 
environment for  blaOXA-204  were isolated from patients 
14, 19, 20 and 21;  Figure 2  and  Table 2). Finally, 14 
patients were infected (four biliary infections, one 
hepatic abscess and nine urinary tract infections) and 
12 patients were colonised. For one patient (Patient 
19), the acquired biliary tract infection resulted in fatal 
Table 1
Primers used for Tn2016 PCR mapping
Primer Sequence (5’ to 3’) PCR product size (bp)
ISEcp1A TGCAGGTCTTTTTCTGCTCC
1,099
ISKpn15–5’ext CTGCGTGGCTATGTGCTCTG
ISKpn15-for GGTGTTCGGTGACGAGATTAGC
1,955
OXA-48–5’ext ATTCCAGAGCACAACTACGC
ISEcp1P + TGCTCTGTGGATAACTTGCA
998
OXA48B GAGCACTTCTTTTGTGATGGC
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septicaemia. Overall, this outbreak spread in 10 health 
institutions including one endoscopy centre where 
patients received the endoscopy with the suspected 
endoscope, six hospitals, one private clinic and two 
retirement homes (Figure 2).
In February 2014, the sequestration of the endoscope 
immediately stopped further detection of colonised 
patients, confirming that the endoscope was probably 
the source of this outbreak. However, audit of the repro-
cessing procedures that were performed in accordance 
with the manufacturer guidelines and French recom-
mendations [25,26] did not reveal any dysfunction. 
In microbiological investigations of the incriminated 
endoscope in February 2014, no OXA-204-producing 
strain was recovered from the device. However, poly-
morphic human flora was cultured from the endoscope 
and three additional reprocessing procedures were 
needed until the device was clean enough to conform 
with the French recommendations [26].
Discussion 
We analysed different features of the OXA-204-
positive enterobacterial isolates collected between 
October 2012 and May 2014 at the NRC for Antibiotic 
Resistance (division of carbapenemase-produc-
ing Enterobacteriaceae), France.
According to the EUCAST guidelines, 21 of the 29 OXA-
204 producers remained susceptible to imipenem and 
meropenem, complicating their detection. Similar phe-
notypical characteristics have already been reported 
for OXA-48-producers [27]. OXA-204-producing  E. 
coli seem to be more susceptible to those two carbap-
enems than OXA-204-producing  K. pneumoniae. By 
contrast, ertapenem appeared to be the best carbap-
enem to detect those strains since 21 of the 29 isolates 
were resistant. All strains were resistant to extended-
spectrum cephalosporins because of the production 
of the beta-lactamase CMY-4, thus limiting therapeutic 
options. In addition, 18 of the 29 OXA-204 producing 
isolates also produced a CTX-M-15-type ESBL, compro-
mising the efficiency of cefepime. However, most of the 
Table 2
Phenotypic and genetic features associated with OXA-204-beta-lactamase producing Enterobacteriaceae, France, 2012–14 
(n = 29)
Species /
clone
Number of 
isolates
Sequence 
type
Beta-lactams  
MIC range (µg/mL) Genetic 
location 
of blaOXA-204
Incompatibility 
group of 
blaOXA-204-carrying 
plasmid
Non-beta-
lactam-
associated 
resistance 
(number of 
strains)
Associated broad-
spectrum beta-
lactamasesa(number 
of strains)
Close genetic 
environment 
of the blaOXA-204 
geneERT IMP MER
Escherichia coli
A 12 ST90 0.38–32 0.19–12 0.094–6 Plasmid IncA/C
Gm (12), Tm 
(12), Q (12), 
Tet(12), Sxt 
(10)
CMY-4 (12), CTX-M-
15 (9) Tn2016
B 1 ST104 0.5 0.38 0.25 Plasmid IncA/C Tet CMY-4 ISEcp1
C 1 ST617 1 0.25 0.25 Plasmid IncA/C Gm, Tm, Q, Tet, Sxt CMY-4 Tn2016
D 1 ST949 0.75 0.5 0.19 Plasmid IncA/C Q, Tet, Sxt CMY-4 ISEcp1
Klebsiella pneumoniae
A 9 ST147 3– >32 1–12 1– >32 Plasmid IncA/C
Ak (1), Tm (8), 
Gm (6), Q (9), 
Tet (9), Sxt 
(8), Fos (7)
CMY-4 (9), CTX-M-15 
(9) ISEcp1
B 1 ST1683b 3 0.25 0.19 Plasmid IncA/C Gm, Tm, Tet CMY-4 Tn2016
C 1 ST1709b 1 0.25 0.12 Plasmid IncA/C Gm, Tm, Tet, Tig CMY-4 Tn2016
Proteus 
mirabilis 1 ND 1.5 0.38 0.094 Plasmid IncA/C Gm, Tm, Sxt CMY-4 ISEcp1
Citrobacter 
freundii 1 ND 3 1 0.5 Plasmid IncA/C
Gm, Tm, Q, 
Tet, Tig CMY-4 Tn2016
Serratia 
marcescens 1 ND 0.75 0.75 0.5 Plasmid IncA/C
Gm, Tm, Tet, 
Tig CMY-4 Tn2016
Ak: amikacin; ERT: ertapenem; Fos: fosfomycin; Gm: gentamicin; IMP: imipenem; MER: meropenem; MIC: minimum inhibitory concentration; 
ND: not determinable; Q: quinolones; Sxt: sulfamethoxazole-trimethoprim; Tet: tetracycline; Tig: tigecycline; Tm: tobramycin.
a Resistance markers co-harboured on the blaOXA-204-carrying plasmid are underlined.
b ST1683 ad ST1709 are new sequence types.
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isolates (27/29) remained susceptible to colistin, tige-
cycline, amikacin and fosfomycin.
We investigated the clonal distribution of OXA-
204-positive isolates and identified two main STs. 
Twelve of the 15  E. coli  isolates belonged to ST90. 
To our knowledge, this ST has not been reported to 
be associated with OXA-48-like-producing  E. coli. 
However, the occurrence of other carbapenemases 
such as NDM-1 had been reported twice in ST90  E. 
coli  isolates, and a link with India was demonstrated 
[28,29]. Nine of 11 the K. pneumoniae isolates belonged 
to ST147, which was the predominant ST in our study. 
The ST147  K. pneumoniae  clone is linked to the 
worldwide spread of different carbapenemases (OXA-
48, OXA-204, NDM-1, NDM-5, VIM-1, KPC-2) and ESBL 
(SHV-12, CTX-M-15) [15,27,30-33]. Additional single STs 
were identified, namely ST617, ST104 and ST949 for E. 
coli and two new STs (ST1683 and ST1709) for K. pneu-
moniae, supporting the hypothesis that a single blaOXA-
204-positive plasmid is spreading among various genetic 
backgrounds (Figure 2). One OXA-204-positive ST617 E. 
coli  strain was identified in Tunisia in 2015 [14]. Of 
note, ST617 is a widespread ST type, associated with 
various beta-lactamase-encoding genes (CTX-M-15, 
NDM-1) [34,35]. Interestingly, ESBL-producing ST617 E. 
coli were recently recovered from companion and farm 
animals in Tanzania and from water samples in Tunisia 
[36,37].
In this study, between October 2012 and May 2014, 
OXA-204 ST90 E. coli strains were regularly identified. 
Concomitantly, OXA-204-producing ST147  K. pneu-
moniae  isolates were identified in the same area 
(Paris and its suburbs) between August 2013 and May 
2014. Although microbiological investigations were 
not conclusive, our results strongly suggest that the 
endoscope may have been contaminated with at least 
two OXA-204 producing isolates: ST90  E. coli  that 
co-harboured a blaCTX-M-15-carrying plasmid and ST147 K. 
pneumoniae (Figure 2). Interestingly, following this out-
break the manufacturer released several notes concern-
ing the reprocessing procedures of the endoscope [38] 
and updated in June 2015 the manual for reprocessing 
procedures which now includes reference to a novel 
brush (MAJ-1888/MyBrush) [39]. This dual outbreak was 
controlled in May 2014 after the sequestration of the 
endoscope suspected to be the source of the outbreak. 
Gastrointestinal endoscopy has previously been identi-
fied as a risk factor for infection and colonisation with 
carbapenemase-producing Enterobacteriaceae [40].
Four patients were colonised or infected with more 
than one OXA-204-producing enterobacterial species. 
Three patients were colonised with one OXA-204-
positive  E. coli  plus one OXA-204-producing  K. pneu-
moniae, and one patient with one OXA-204-positive E. 
coli  plus one OXA-204-producing  K. pneumoniae  and 
one additional OXA-204-positive S. marcescens. Those 
results suggest a high conjugative ability of the OXA-
204-IncA/C-type plasmids. As shown for OXA-48 [41], 
OXA-204 is associated with an efficient genetic vehi-
cle, thus promoting the interspecies spread of  blaOXA-
204-carrying plasmids among various enterobacterial 
species in the same patient. In addition, as previ-
ously reported, endoscopy-associated transmission of 
carbapenemase-producing Enterobacteriaceae (CPE) 
might result in long-term carriage of the acquired CPE 
[42] that poses a risk of further secondary outbreaks 
from primary infected or colonised patients. Indeed, 
these patients are often at high risk of recurrence of 
a hepato-biliary infection that needs to be treated by 
endoscopic procedures. To decrease the risk of sec-
ondary outbreaks, we propose making a note in these 
these CPE patients’ record and systematically screen-
ing them before performing any endoscopy.
The transposon Tn2016  was identified in 17 of the 29 
isolates. The truncation of ISEcp1 by another IS may have 
stabilised this genetic structure on the IncA/C plasmid 
by disrupting the ISEcp1 transposase activity. However, 
in the 12 remaining isolates, the ISEcp1 copy was intact 
and we can therefore speculate that the transposon 
made of ISEcp1and  blaOXA-204  is functional. ISEcp1  is 
known to be an efficient genetic vehicle for spreading 
clinically significant beta-lactamases such as CMY or 
CTX-M-15 [43,44]. The association of  blaOXA-204  with an 
intact copy of ISEcp1  on the one hand and an IncA/C 
broad host range plasmid on the other might increase 
the capability of the  blaOXA-204  to disseminate among 
various genetic elements (plasmids, chromosome, etc) 
and among various bacterial species.
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